Michael A. Darwin

Michael A. Darwin is a declared insider of Biocryst Pharmaceuticals Inc, with filings sourced from SEC (Form 4). The record holds 30 filings, for trades running from 15 March 2006 to 31 July 2008.

On the open market, the record shows 2 purchases worth €6,245 and 22 sales worth €361k. Taken together, the sales exceed the purchases by €354k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 option exercises. In 2008 alone, the filings show 2 purchases and no sales.

The latest filing, published on 4 August 2008, reports an open-market purchase of €3,093 in Biocryst Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.